- Report
- January 2024
- 200 Pages
Global
From €4885EUR$5,000USD£4,078GBP
- Report
- November 2023
- 175 Pages
Global
From €4885EUR$5,000USD£4,078GBP
- Report
- October 2024
- 180 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- November 2024
- 304 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 297 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 268 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 276 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- November 2024
- 486 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- November 2024
- 169 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- November 2024
- 197 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 196 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 194 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 181 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 194 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 182 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 183 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 196 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 194 Pages
Global
From €5325EUR$5,450USD£4,445GBP
- Report
- November 2024
- 179 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- November 2024
- 269 Pages
Global
From €5325EUR$5,450USD£4,445GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more